Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

BioTek

BioTek Instruments, Inc., designs, manufactures, and distributes life science instrumentation. Its product line inclu... read more Featured Products: More products

Download Mobile App




Newly Augmented Microdispenser System Replaces Five Liquid Handling Instruments

By LabMedica International staff writers
Posted on 13 Apr 2014
Upgrades to a highly regarded microdispenser system allows the instrument fo replace up to five separate liquid handlers, saving operator time and instrumentation costs

The new BioTek (Winooski, VT, USA) MultiFlo FX Microplate Dispenser is now available with optional RAD (Random Access Dispense) technology to further extend its application range and flexibility. More...
RAD technology offers single-channel dispensing to random individual microplate wells along with rapid reagent dispensing into large volume wells of 6- to 24-well microplates. MultiFlo FX can also be separately configured with an optional wash module for 6- to 384-well plates.
The Multiflo FX accommodates microplate types ranging from 6- to 1536-wells, and dispenses volumes of from one to three microliters accurately and precisely. BioTek's proprietary angled dispensing ensures compatibility with all dispense protocols including media exchanges with loosely adherent cell monolayers. For assays requiring minimum reagent usage, the MultiFlo's prime volume is less than one milliliter. A built-in priming trough is designed to allow both recovery of reagents or to send primed reagent directly to waste.

MultiFlo FX was especially designed for sensitive cell-based assays, ELISAs, and bead-based assays, with angled dispense tips and flexible flow rates to maintain cell integrity.

Due to its small footprint and base height of less than 20.3 cm, the MultiFlo FX readily fits on any laboratory bench or robotic system. It is easily integrated with the BioTek BioStack Microplate Stacker, allowing up to 75 plates to be dispensed automatically. Simplified programming via intuitive on-board software and a color touch screen display enable control of dispense patterns, and two integrated USB ports provide convenient file transfer and storage options.

“Microplate-based bulk dispensing can be complex, especially in an automated system,” said Jason Greene, BioTek product manager. “We specifically designed MultiFlo FX to streamline this process, providing more value through multitasking, and time savings.”

Related Links:
BioTek



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.